MEIP Company Profile and Key Details
MEI Pharma, Inc.
MEIP Stock Price Chart
Stock Price Today
MEI Pharma, Inc. (MEIP) stock surged +1.06%, trading at $2.85 on NASDAQ, up from the previous close of $2.82. The stock opened at $2.85, fluctuating between $2.82 and $2.88 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymphoma, as well as in Phase Ib multi-arm trial to treat B-cell malignancies; and Voruciclib, an oral cyclin-dependent kinase 9 inhibitor, which is in Phase Ib clinical trial for acute myeloid leukemia and B-cell malignancies. It also develops ME-344, a mitochondrial inhibitor targeting the oxidative phosphorylation complex that is in Phase I clinical trial for the treatment of human epidermal growth factor receptor 2 negative breast cancer; and Pracinostat, an oral available histone deacetylase inhibitor, which is in Phase II clinical trial to treat patients with myelodysplastic syndrome. MEI Pharma, Inc. has a license, development, and commercialization agreement with Kyowa Kirin Company; a clinical collaboration with BeiGene, Ltd.; a license, development, manufacturing, and commercialization agreement with Helsinn Healthcare SA; and a license agreement with Presage Biosciences, Inc. The company was formerly known as Marshall Edwards, Inc. and changed its name to MEI Pharma, Inc. in July 2012. MEI Pharma, Inc. was incorporated in 2000 and is headquartered in San Diego, California.
Company Information
| Employees | 28 |
| Beta | 0.71 |
| Sales or Revenue | $65.30M |
| 5Y Sales Change% | 8.361% |
| Fiscal Year Ends | June |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
MEI Pharma, Inc. (NASDAQ: MEIP) stock price is $2.85 in the last trading session. During the trading session, MEIP stock reached the peak price of $2.88 while $2.82 was the lowest point it dropped to. The percentage change in MEIP stock occurred in the recent session was 1.06% while the dollar amount for the price change in MEIP stock was $0.03.
The NASDAQ listed MEIP is part of Biotechnology industry that operates in the broader Healthcare sector. MEI Pharma, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. David M. Urso B.A., Esq., J.D.
Chief Executive Officer, Pres & Director
Dr. Alejandro D. Ricart M.D.
Senior Vice President of Clinical Devel.
Mr. Brian G. Drazba B.A., C.P.A., CPA
Chief Financial Officer & Sec.
Dr. Daniel P. Gold
Pres, Chief Executive Officer & Director
Dr. Richard G. Ghalie
Chief Medical Officer
Mr. David A. Walsey J.D., L.L.M.
Senior Vice President of Corporation Affairs
Mr. Eugene Park
Vice President of Marketing
Dr. Karen E. Potts Ph.D.
Senior Vice President of Regulatory Affairs
Ms. Tina Clark Beamon Esq., J.D.
Chief Compliance Officer
Ms. Anne Frese
Chief People Officer
Ms. Virginia Sankey
Vice President of Fin.
Dr. Eric Deng Ph.D.
Vice President of Technical Operations
Ms. Yomara Gomez-Naiden
Senior Vice President of Quality
Dr. Robert D. Mass
Strategic Advisor
Mr. Justin J. File
Chief Financial Officer & Corporation Sec.
Mr. Brian G. Drazba B.A., CPA, CPA
Chief Financial Officer & Sec.
MEIP's closing price is 23.91% higher than its 52-week low of $2.30 where as its distance from 52-week high of $4.97 is -42.66%.
Number of MEIP employees currently stands at 28.
Official Website of MEIP is: https://www.meipharma.com
MEIP could be contacted at phone 858 369 7100 and can also be accessed through its website. MEIP operates from 11455 El Camino Real, San Diego, CA 92130, United States.
MEIP stock volume for the day was 9.55K shares. The average number of MEIP shares traded daily for last 3 months was 53.12K.
The market value of MEIP currently stands at $18.99M with its latest stock price at $2.85 and 6.66M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com